EQRx Future Growth
Future criteria checks 2/6
EQRx is forecast to grow revenue at 123.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 24.1% |
| Revenue growth rate | 123.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 Oct 2023 |
Recent future growth updates
No updates
Recent updates
We're Hopeful That EQRx (NASDAQ:EQRX) Will Use Its Cash Wisely
Jul 25
EQRx (NASDAQ:EQRX) Is In A Good Position To Deliver On Growth Plans
Feb 22We're Not Very Worried About EQRx's (NASDAQ:EQRX) Cash Burn Rate
Nov 08EQRx: Saving American Lives, Made Possible By Low Cost Chinese Drugs
Aug 28 EQRx GAAP EPS of -$0.17 beats by $0.03
Aug 11Here's Why We're Not Too Worried About EQRx's (NASDAQ:EQRX) Cash Burn Situation
Jul 24We Think EQRx (NASDAQ:EQRX) Can Afford To Drive Business Growth
Apr 08EQRx (NASDAQ:EQRX) Is In A Good Position To Deliver On Growth Plans
Dec 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 3 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 1 | N/A | N/A | N/A | 1 |
| 12/31/2023 | N/A | N/A | N/A | N/A | 1 |
| 9/30/2023 | N/A | -260 | -332 | -330 | N/A |
| 6/30/2023 | N/A | -263 | -332 | -330 | N/A |
| 3/31/2023 | N/A | -272 | -320 | -319 | N/A |
| 12/31/2022 | N/A | -169 | -288 | -287 | N/A |
| 9/30/2022 | N/A | -146 | -262 | -262 | N/A |
| 6/30/2022 | N/A | -100 | -242 | -242 | N/A |
| 3/31/2022 | N/A | -53 | -214 | -214 | N/A |
| 12/31/2021 | N/A | -100 | -184 | -183 | N/A |
| 9/30/2021 | N/A | -279 | -276 | -275 | N/A |
| 6/30/2021 | N/A | -296 | -289 | -286 | N/A |
| 3/31/2021 | N/A | -269 | -260 | -257 | N/A |
| 12/31/2020 | N/A | -250 | -244 | -242 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if EQRX's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if EQRX's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if EQRX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: EQRX's revenue (123.3% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: EQRX's revenue (123.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EQRX's Return on Equity is forecast to be high in 3 years time